品牌分类
品牌咨询
- phoenix pharmaceuticals 拜力十周年
- 豚鼠内皮素1(ET1)ELISA试剂盒厂家 仪器交易网
- Avidity Biosciences完成1亿美元C轮融资投融资亿邦动力网
- 美国Avidity
- avidity代理深圳欣生源生物科技有限公司
- 生物素蛋白连接酶_生物素蛋白连接酶【价格,厂家,图片,批发,采购】
- 特别报道:2020年十大生物技术IPO
- avidity|bulk BirA 蚂蚁淘进口试剂平行进口
- 亚洲业务_亚洲业务最新消息,新闻,图片,视频_聚合阅读_新浪网
- 【环孢素厂家_环孢素供应商】黄页88网
- 小鼠高铁血红蛋白 MHB elisa试剂盒 厂家供应 臻科生物
- 2021年4月现货产品列表,欢迎选购!
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
商品描述
Product Information
Supplied as: 1 vial containing 100µL of 1mg/mL affinity-purified monoclonal antibody in PBS. Store at 4°C. Storage at -20°C is acceptable but not recommended. Do not freeze thaw repeatedly. Contains thimerosal as a preservative.
Avidity带有AviTag标签的人类全长ORF克隆已经被构建在多种T7和CMV启动子表达系统,可以立即购买使用。AviTag标签蛋白可以被体内或体外的生物素连接酶生物素化,而且抗生物素蛋白或链霉亲和素可以专一地与生物素结合,正基于这两个反应,AviTag?技术可以应用于蛋白的固定,纯化和显影。 虽然Avidity是一个小公司,科学带来的好处及其AviTag已得到认可。目前, AviTag技术已经在22个国家的世界十大制药公司和研究人员中得到认可。 Avidity Avitag™ Technology Avidity develops and sells molecular affinity tools for connecting molecules. Our patented AviTag™ technology employs a highly targeted enzymatic conjugation of a single biotin on a unique 15 amino acid peptide tag using the biotin ligase (BirA) from E. coli. AviTag™ sequence is GLNDIFEAQKIEWHE. Oriented on streptavidin-coated surfaces, this creates an ideal presentation for molecular binding interactions. The scientific benefits of Avidity's AviTag Technology have garnered notice. Currently, AviTag technology is licensed by seven of the world's top ten pharmaceutical companies and is used by researchers in 22 countries. Company History Avidity, LLC was founded in 1996 by Millard Cull, Larry Lansing, Dr. Ron Gill, and Dr. Mark Seville to develop peptide tags and molecular biology products based upon the extraordinary affinity of biotin for avidin or streptavidin. While working at Affymax as a researcher, Millard was involved in the discovery of the AviTag technology, saw its commercial potential, and obtained the exclusive rights from Affymax. He started Avidity as a reagent company that sublicenses the right to use the AviTag technology to other companies and sells products for use with the technology. AviTag History AviTag is a patented biotin-tagging technology discovered at Affymax by Dr. Peter Schatz from a Directed Evolution approach called "Peptides-on-Plasmids." The Directed Evolution approach identified a number of peptide sequences that can be biotinylated by the BirA enzyme of E. coli, and the best of these sequences was called the AviTag. E. coli enzyme BirA biotinylates the 15 amino acid AviTag twice as fast as its natural substrate, the Biotin Carboxyl Carrier Protein (BCCP). The enzymatic biotinylation of proteins using AviTag technology is preferred over chemical biotinylation of proteins because BirA enzyme gently, and highly specifically, labels the lysine residue of the AviTag. Prior to the AviTag, the smallest biotin-accepting domain was comprised of 75 amino acids.

